April 2026 in “Therapeutic Advances in Drug Safety” This study developed a new clustering model to improve detection of drug-induced cognitive disorder risk signals, finding that it identified drugs with moderate risk signals, like Carbidopa/Levodopa, missed by traditional methods, enhancing clinical assessment comprehensiveness.
April 2026 in “Frontiers in Pharmacology” This study revealed significant signals of drug-related cognitive disorders in several medications that lack relevant FDA label warnings, suggesting a need for increased clinical awareness and potential label updates.
2 citations
,
March 2022 in “Indian Journal of Psychiatry/Indian journal of psychiatry” This article reviews the psychiatric conditions associated with HIV, highlighting the bidirectional relationship and management challenges but presents no new research findings.
5 citations
,
February 2010 in “Expert Review of Dermatology” This article reviews the interconnectedness of the skin and nervous system and discusses various treatment options for psychophysiological skin disorders, reporting no new clinical results.
December 2024 in “Ukrains kyi Visnyk Psykhonevrolohii” This study found that women with mixed alopecia experienced significant cognitive impairments, particularly those with adaptation disorders, with symptoms like rapid fatigue and impaired concentration being most prevalent. The cognitive patterns are complex and require further investigation to inform tailored rehabilitation strategies.
21 citations
,
April 2015 in “Psychology Research and Behavior Management” This review evaluates various cognitive-behavioral interventions for trichotillomania but does not report new clinical findings, highlighting the need for further research on their efficacy.
14 citations
,
December 2007 in “Journal of The European Academy of Dermatology and Venereology” This paper discusses the use of lifestyle drugs by individuals without medical conditions to enhance appearance, highlighting that such usage may worsen emotional disorders and suggests these should be treated with psychotherapy or psychopharmacotherapy.
9 citations
,
February 2016 in “Cambridge University Press eBooks” This chapter reviews the role of self in disorders related to the OCD spectrum, such as hoarding disorder, body dysmorphic disorder, and trichotillomania, and reports no new findings.
June 2026 in “International Journal of Innovative Technologies in Social Science” This review explores how metabolic and psychological factors contribute to binge eating disorder in women with PCOS and highlights the need for non-punitive, comprehensive management strategies.
January 2015 in “The Encyclopedia of Clinical Psychology” This review discusses trichotillomania treatments, highlighting that habit reversal training shows promise for children and adolescents, although further research is needed, as existing literature on this age group is sparse.
March 2026 in “Actas Dermo-Sifiliográficas” In this study, dermatologists from the Spanish Hair and Nail Disorders Group viewed post-finasteride syndrome as rare and primarily of psychiatric origin, with limited scientific evidence supporting its existence.
June 2024 in “Ukrains kyi Visnyk Psykhonevrolohii” This study found that among women with diffuse alopecia, depressive symptoms were common, affecting more than a third of patients, particularly those with mixed alopecia, where the prevalence was three times higher compared to metabolic alopecia.
39 citations
,
October 2015 in “Case Reports” In this case series, four adults developed severe, disabling multisymptom illness potentially linked to fluoroquinolone use, which persisted and progressed even after discontinuation of the drug.
6 citations
,
January 2013 in “Urology” This case report describes an 8-year-old child with penile tourniquet syndrome due to a constricting thread, which led to partial distal penile amputation and required surgical intervention.
2 citations
,
July 2016 in “Pharmacopsychiatry” This case report describes a non-mosaic Turner-Syndrome individual with global cerebral atrophy, significant cognitive impairment, and severe treatment-resistant schizophrenia.
138 citations
,
March 2001 in “Clinics in Dermatology” This review discusses the relationship between perceived stress and hair loss or graying, exploring hair follicles as a model system but reports no new clinical results.
1 citations
,
December 2014 in “Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology” This study reports that a 15-year-old with trichotillomania showed improvement with aripiprazole treatment, though no consensus on treatment exists in the literature.
1 citations
,
September 2003 in “The Journal of the American Animal Hospital Association/Journal of the American Animal Hospital Association” This abstract describes a study that found fluoxetine HCl can be absorbed through cat skin when applied as a transdermal gel, though its bioavailability was about 10% compared to oral dosing.
January 2026 in “Behavioral Sciences” In this observational study, among 135 Italian outpatients with alopecia areata, OCD symptoms were prevalent in 18.5%, and emotional distress was found in 20.7%, with emotional distress mediating the relationship between illness perceptions and OCD symptomatology.
May 2022 in “European medical journal” This case report describes a rare instance of a patient with trichotillomania also developing a gastric trichobezoar, leading to Rapunzel syndrome.
1 citations
,
March 2024 in “The Journal of Dermatology” In this study, a multidisciplinary psychodermatology service treating children and young people with compulsive hair pulling reported varied success, with 45.4% achieving complete resolution and 36.4% seeing substantial improvement, suggesting a hybrid care model may benefit patient engagement and therapy outcomes.
July 2026 in “UCLA Department of Medicine Clinical Insights” This case report illustrates how cognitive-behavioral therapy effectively reduced hair-pulling behavior and improved self-confidence and interpersonal relationships in a patient with trichotillomania.
November 2012 in “Hair transplant forum international” This article discusses Dr. Rajput's study on body dysmorphic disorder in hair loss patients and their improvement post-hair restoration, but it presents no original findings itself.
282 citations
,
October 2006 in “The Journal of Clinical Endocrinology and Metabolism” This review discusses guidelines for androgen use in women and concludes that more research is needed before recommending testosterone due to insufficient evidence on safety and efficacy.
28 citations
,
May 2013 in “The Journal of Steroid Biochemistry and Molecular Biology” This review presents substantial evidence supporting testosterone use for hypoactive sexual desire disorder in postmenopausal women, but notes safety concerns with off-label prescribing due to lack of approved formulations.
August 2025 in “Brazilian Journal of Hair Health” This study found that 29.6% of patients seeking treatment for hair loss meet the criteria for hair-related body dysmorphic disorder, significantly higher than in general dermatology patients.
May 2025 in “Anatolian journal of obstetrics and gynecology research.” This source highlights the essential role of androgens in women's health, noting their impact on various body systems and the critical need for more research on androgen therapies regarding side effects, patient selection, and laboratory standardization.
1 citations
,
November 2023 in “Brain and behavior” This study found that spironolactone improved cognitive performance in patients with bipolar disorder experiencing manic episodes, but did not significantly affect manic symptoms, recommending further research with larger sample sizes and longer follow-ups.
7 citations
,
January 2020 in “Journal of King Saud University - Science” This study found that celery supplementation improved cognition and behavioral disorders in LPS-exposed mouse offspring by increasing levels of dopamine, acetylcholinesterase, and serotonin in the forebrain.
38 citations
,
January 2014 in “International Journal of Endocrinology” This review highlights that children with adrenal disorders may experience neurological and psychiatric symptoms, with potential long-term cognitive and behavioral effects from excess glucocorticoids.